Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.
TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Solid lipid nanoparticles surface modified with anti-Contactin2 or anti-Neurofascin for brain targeted delivery of medicines.
The effects of progressive muscular relaxation as a nursing procedure used for those who suffer from stress due to multiple sclerosis.
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation.
Aquaporin modulators: a patent review (2010-2015).
Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in Children: Experience in a Tertiary Center, Upper Egypt.
[Immunity impact of pregnancy on the experience of the Obstetrics and Gynecology Department of Moulay Ismail Military Hospital].
Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).
A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia.
Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway.
Acute Generalized Weakness.
Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis.
Neurological Nuance: Hodgkin Lymphoma Presenting With Guillain-Barré Syndrome.
Neurological deficit following stereotactic radiosurgery for trigeminal neuralgia.
CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags.
IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Myelin plasticity in the central nervous system.
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF.
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

Pages